BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hedström J, Haglund C, Haapiainen R, Stenman UH. Serum trypsinogen-2 and trypsin-2-alpha(1)-antitrypsin complex in malignant and benign digestive-tract diseases. Preferential elevation in patients with cholangiocarcinomas. Int J Cancer. 1996;66:326-331. [PMID: 8621252 DOI: 10.1002/(sici)1097-0215(19960503)66:3<326::aid-ijc10>3.0.co;2-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 O'Neill RS, Stoita A. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket? World J Gastroenterol 2021; 27(26): 4045-4087 [PMID: 34326612 DOI: 10.3748/wjg.v27.i26.4045] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
2 Kamer E, Unalp HR, Derici H, Tansug T, Onal MA. Early diagnosis and prediction of severity in acute pancreatitis using the urine trypsinogen-2 dipstick test: A prospective study. World J Gastroenterol 2007; 13(46): 6208-6212 [PMID: 18069761 DOI: 10.3748/wjg.v13.i46.6208] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]